Allergic contact dermatitis from topical carmustine.
Thomson
K F
KF
Leeds General Infirmary, UK.
Sheehan-Dare
R A
RA
Wilkinson
S M
SM
D000279:Administration, Cutaneous; D000368:Aged; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000009:adverse effects*; D002330:Carmustine / Q000008:administration & dosage / Q000009:adverse effects*; D017449:Dermatitis, Allergic Contact / Q000209:etiology*; D005260:Female; D006801:Humans; D016410:Lymphoma, T-Cell, Cutaneous / Q000188:drug therapy; D012878:Skin Neoplasms / Q000188:drug therapy
D018906:Antineoplastic Agents, Alkylating; D002330:Carmustine